Shionogi Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for SHIONOGI INC, and what generic alternatives to SHIONOGI INC drugs are available?
SHIONOGI INC has six approved drugs.
There are nine US patents protecting SHIONOGI INC drugs.
There are one hundred and nineteen patent family members on SHIONOGI INC drugs in thirty-seven countries and forty-two supplementary protection certificates in sixteen countries.
Summary for Shionogi Inc
| International Patents: | 119 |
| US Patents: | 9 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 6 |
Drugs and US Patents for Shionogi Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | 9,238,657 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Shionogi Inc | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 8,530,668 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | DISCN | Yes | No | 7,294,342 | See Plans and Pricing | See Plans and Pricing | ||||
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-002 | Sep 9, 1993 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
| Shionogi Inc | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 9,427,402 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Shionogi Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-004 | Sep 9, 1993 | 4,816,456 | See Plans and Pricing |
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-001 | Sep 9, 1993 | 4,631,286 | See Plans and Pricing |
| Shionogi Inc | RYBIX ODT | tramadol hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021693-001 | May 5, 2005 | 6,106,861 | See Plans and Pricing |
| Shionogi Inc | RYBIX ODT | tramadol hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021693-001 | May 5, 2005 | 5,464,632 | See Plans and Pricing |
| Shionogi Inc | COGNEX | tacrine hydrochloride | CAPSULE;ORAL | 020070-003 | Sep 9, 1993 | 4,631,286 | See Plans and Pricing |
| Shionogi Inc | ULESFIA | benzyl alcohol | LOTION;TOPICAL | 022129-001 | Apr 9, 2009 | 6,793,931 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SHIONOGI INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 250 mg/vial and 500 mg/vial | ➤ Subscribe | 2011-10-11 |
| ➤ Subscribe | Lotion | 5% | ➤ Subscribe | 2016-04-11 |
International Patents for Shionogi Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 103393678 | See Plans and Pricing |
| Brazil | PI0921701 | See Plans and Pricing |
| China | 103130739 | See Plans and Pricing |
| Taiwan | I422371 | See Plans and Pricing |
| Portugal | 3190115 | See Plans and Pricing |
| Costa Rica | 20110144 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shionogi Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2960244 | 2020035 | Norway | See Plans and Pricing | PRODUCT NAME: CEFIDEROKOL, EVENTUELT PA FORMEN AV ET FARMASOEYTISK AKSEPTABELT SALT ELLER SOLVAT; REG. NO/DATE: EU/1/20/1434 20200508 |
| 2960244 | LUC00179 | Luxembourg | See Plans and Pricing | PRODUCT NAME: CEFIDEROCOL, EVENTUELLEMENT SOUS LA FORME D'UN SEL OU D'UN SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE; AUTHORISATION NUMBER AND DATE: EU/1/20/1434 20200424 |
| 0566709 | C300152 | Netherlands | See Plans and Pricing | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
| 0566709 | SPC/GB04/012 | United Kingdom | See Plans and Pricing | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| 2184279 | CR 2019 00038 | Denmark | See Plans and Pricing | PRODUCT NAME: LUSUTROMBOPAG OG FARMACEUTISK ACCEPTABLE SALTE ELLER SOLVATER DERAF; REG. NO/DATE: EU/1/18/1348 20190220 |
| 0528678 | CR 2009 00003 | Denmark | See Plans and Pricing | PRODUCT NAME: DORIPENEM, HERUNDER DORIPENEMMONOHYDRAT; REG. NO/DATE: EU/1/08/467/001 20080725 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
